New England Journal of Medicine Retracts Amgen Drug Trial Paper Amid Data Integrity Concerns
The New England Journal of Medicine (NEJM) has retracted a significant research paper that underpinned the use of Amgen’s drug Tavneos. The retraction follows concerns raised about the integrity of the patient outcome data used in the pivotal trial, with allegations that the data may have been altered and that some researchers involved in the […]